Industry collaboration
Industry collaboration
We work with industry through contract research, co-investment and joint development. Most partners and projects are covered by confidentiality agreements, so this page describes how we engage rather than who with. We are happy to discuss specifics under NDA.
$14.1Mtotal research funding as investigator since 2022
$4.0M+held as Lead Investigator, Founder or CIA
SA Healthcollaborations across the state health service: RAPIDx, AI scribe, Pharmacy review and Cardiomics
Who we work with
What we offer a company
- Contract research with a clinician-led group that owns the clinical question, not just the model.
- A demonstrated path from algorithm to health-service deployment, including clinical governance, data sovereignty and safety evaluation.
- Regulatory and deployment experience, with intellectual property generated under industry contracts.
- Access to AIML compute, with 200+ NVIDIA A100 GPUs and over 5+ PB of secure storage.
How engagements have worked
The pattern that works is a scoped first contract on a well-defined clinical question, an extension once the method proves out, then a translation and regulatory pathway built on the result. Contract, extension, translation. Engagements that skip the first step rarely reach the third.
It helps to talk early, while the clinical question is still open and before the data has been fixed.